Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-03-05 | 2024-03-01 | GMED | Huller Kelly | SVP, GC, Corp. Sec | S - Sale+OE | $54.10 | -7,500 | 3,115 | -71% | -$405.7K |
| DT | 2024-03-05 | 2024-03-01 | GMED | Huller Kelly | SVP, GC, Corp. Sec | M - OptEx | $24.90 | +7,500 | 7,500 | New | +$186.8K |
| DT | 2024-03-05 | 2024-03-01 | GMED | Huller Kelly | SVP, GC, Corp. Sec | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-01 | S | D | 3,115 | $54.53 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $54.43 - $54.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) to this Form 4. |
| 2 | Common | Class A Common Stock | 2024-03-01 | M | A | 7,500 | $24.90 | 7,500 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-03-01 | S | D | 4,385 | $53.79 | 3,115 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $53.36 - $54.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) to this Form 4. |
| 4 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-03-01 | M | D | 7,500 | $0.00 | 0 | D | $24.90 · — to 2024-03-04 | 7,500 Class A Common Stock | (F4) These options were granted on March 4, 2014 and are fully vested. |